USSTOCK.TODAY
Market Closed
Log in Sign up

Axsome Therapeutics vs. Moderna: Earnings and Valuation Comparison

Nasdaq +1 ·

AXSM
AXSM Axsome Therapeutics Inc
$172.97 -0.79%
View chart & analysis →
  1. 1Axsome Therapeutics commercializes Auvelity and Sunosi.
  2. 2Axsome Therapeutics recorded revenue of approximately $638.5 million in FY 2025.
  3. 3Axsome Therapeutics appears much cheaper than Moderna based on revenue and future earnings.

So what's the key point?

Axsome Therapeutics generated about $638.5 million in revenue from drug sales. Compared to Moderna, the company's stock price looks inexpensive relative to its earnings.

Source Nasdaq +1 · View original ↗

Related 3-line summaries

Anthropic and OpenAI Plan IPOs; Infrastructure Companies in Focus The Motley Fool +1 · 45m agoConstellation Energy signs 890MW new nuclear power supply agreement with Google The Motley Fool +1 · 1h agoCiti Upgrades Flutter Entertainment to 'Buy' Schaeffer's Research +1 · 1h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news